Sore arm at injection site; mild fatigue; minor joint aches in back and hips; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 22Oct2021 15:30 (Lot number: EW0176) at the age of 55 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "If covid prior vaccination: Yes" (unspecified if ongoing), notes: If covid prior vaccination: Yes; "Graves' disease", start date: 1970 (unspecified if ongoing), notes: Patient Medical History: Graves' disease, Onset date: 1970's; "GVHD" (unspecified if ongoing); "bone marrow transplant" (unspecified if ongoing); "MDS" (unspecified if ongoing); "Known allergies: antibiotics" (unspecified if ongoing), notes: Known allergies: antibiotics; "Known allergies: Many anti seizure" (unspecified if ongoing), notes: Known allergies: Many anti seizure; "Known allergies: Many anti seizure" (unspecified if ongoing), notes: Known allergies: Many anti seizure; "stroke", start date: 2001 (unspecified if ongoing), notes: Patient Medical History: stroke, ; "heartattack", start date: 2001 (unspecified if ongoing), notes: Patient Medical History: Heartattack; "low thyroid:hypothyroidism", start date: 1990 (unspecified if ongoing), notes: Patient Medical History: Low thyroid, Onset date: 1990's; "aplastic anemia", start date: 2002 (unspecified if ongoing), notes: Patient Medical History: aplastic anemia; "myelodysplastic syndrome", start date: 2009 (unspecified if ongoing), notes: Patient Medical History: myelodysplastic syndrome; "bone marrow transplant", start date: 2009 (unspecified if ongoing), notes: Patient Medical History: bone marrow transplant; "Dry eye" (unspecified if ongoing); "Post menopausal dryness" (unspecified if ongoing), notes: Post menopausal dryness. Concomitant medication(s) included: XIIDRA taken for dry eye (ongoing); SYNTHROID taken for hypothyroidism (ongoing); ASPIRIN [ACETYLSALICYLIC ACID] taken for myocardial infarction (ongoing); PREMARIN taken for vulvovaginal dryness (ongoing); ACETYLCYSTEINE (ongoing); VITAMIN D NOS taken for vitamin d decreased (ongoing); CLOBETASOL taken for graft versus host disease, start date: Oct2021 (ongoing); HYDROCORTISONE taken for graft versus host disease, start date: Oct2021 (ongoing). Vaccination history included: Bnt162b2 (DOSE: 1, Batch/Lot No: EL3248), administration date: 03Mar2021, when the patient was 55 years old, for COVID-19 Immunization; Bnt162b2 (DOSE: 2, Batch/Lot No: EP7534), administration date: 15Apr2021, when the patient was 55 years old, for COVID-19 Immunization. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 22Oct2021 18:00, outcome "recovering", described as "Sore arm at injection site"; FATIGUE (non-serious) with onset 22Oct2021 18:00, outcome "recovering", described as "mild fatigue"; ARTHRALGIA (non-serious) with onset 22Oct2021 18:00, outcome "recovering", described as "minor joint aches in back and hips". Therapeutic measures were not taken as a result of vaccination site pain, fatigue, arthralgia.  Additional information: Prior to vaccination, the patient diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19. The patient had many anti seizure and antibiotics (Known allergies).  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.  Follow up activities were completed.No further information was expected.  No follow-up attempts are possible. No further information is expected.